GC Aesthetics renews its Gold Sponsorship with ISAPS

ISAPS global gold sponsor

As part of our commitment to supporting surgeons in their professional development, GC Aesthetics has announced that we will renew our Gold Sponsorship of the International Society of Aesthetic Plastic Surgery (ISAPS).

GC Aesthetics is committed to supporting surgeons’ medical education, whether through continuous training and networking activities at ISAPS events and workshops, or through our own GCA Academy, a digital training platform that hosts a range of live surgeries, webinars, and lectures sharing best practice.

“In challenging times, we are glad to continue to be a committed partner of the ISAPS organization. Strong partnerships such as this are needed to provide the best service to our customers and provide safe and long-term solutions to every surgeon and patient. GCA working for a better future.”

Carlos Reis Pinto

CEO, GC Aesthetics

“We are very excited that GC Aesthetics has decided to continue as an ISAPS Global Gold Sponsor for another year, and are proud to have GC Aesthetics as one of our esteemed Global Sponsors. We look forward to another fruitful year working together!”

Dr. Dirk Richter

President, ISAPS

ISAPS is the world’s leading professional body for board-certified aesthetic plastic surgeons. Founded in 1970, ISAPS membership includes the world’s best known and respected reconstructive and aesthetic plastic surgeons in over 100 countries on every continent, reflecting the true international mission of the organization.

GC Aesthetics will participate next month in ISAPS’ first-ever virtual conference, the ISAPS Virtual Olympiad which takes place on Saturday, September 5th 2020, with a virtual exhibition on September 4-5, 2020.

We are excited for the continued collaboration opportunities together with ISAPS and the benefits this will bring to plastic, onco plastic and breast surgeons around the world. 

About GC Aesthetics

GC Aesthetics is an established global medical technology company that develops, manufactures in-house and markets a comprehensive range of proprietary aesthetic products that empower patients to feel confident and secure in their personal journey.

Throughout 40 years of commercial presence, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality silicone breast implants under its premium Nagor and Eurosilicone brands, primarily for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries and our products are supported by published 10-year clinical data demonstrating compelling safety and clinical effectiveness.

The company’s vertically integrated strategy enables exceptional clinical, operational and commercial performance, which allows GCA to provide competitively differentiated products to physicians and patients. Through a culture of continuous innovation and dedication to customer-responsiveness, GCA has established itself as a leading provider of medical aesthetics solutions and the partner-of-choice for patients seeking to improve their lives.

We also think you’ll like…

GCA announces new Territory Sales Manager, UK & Ireland

GCA announces new Territory Sales Manager, UK & Ireland

GC Aesthetics is pleased to announce the appointment of Mr. Thanuj Thevar as “GCA Territory Sales Manager – UK/IRE”. Tan has over 10 years of experience in the medical device industry, working with Interventional Radiologists, Breast Radiologists and Surgeons,...

GCA at the MBN Congress 2020

GCA at the MBN Congress 2020

As we continue to engage with plastic surgeons around the world GC Aesthetics (GCA) is delighted to announce we will be participating in the Aesthetic Breast Meeting, MBN 2020 virtual congress, The Webinar Edition. Virtual meetings are becoming more and more prevalent...

GCA committed to ensure Breast Implant Safety

GCA committed to ensure Breast Implant Safety

A position statement regarding our silicone gel and manufacturing processes GC Aesthetics® is focused on safety, quality and reliability. With more than 40 years in the market and over 3 million implants sold during the last 10 yearsDuteille F, et al....